Immunogenicity and safety of SARS-CoV-2 recombinant protein nanoparticle vaccine GBP510 adjuvanted with AS03: interim results of a randomised, active-controlled, observer-blinded, phase 3 trialResearch in context
Summary: Background: GBP510 vaccine contains self-assembling, recombinant nanoparticles displaying SARS-CoV-2 spike receptor-binding domains. We report interim phase 3 immunogenicity results for GBP510 adjuvanted with AS03 (GBP510/AS03) compared with ChAdOx1-S (Vaxzevria, AstraZeneca) in healthy ad...
Similar Items
-
Role of Preoperative Staging Ultrasound for Papillary Thyroid Microcarcinoma
by: Hee Jung Keum, et al.
Published: (2020-11-01) -
Assessment of Maximum Penetration Capacity of Photovoltaic Generator Considering Frequency Stability in Practical Stand-Alone Microgrid
by: Kwang Woo Joung, et al.
Published: (2019-04-01) -
A 3-month survival model after Gamma Knife surgery in patients with brain metastasis from lung cancer with Karnofsky performance status ≤ 70
by: Hangeul Park, et al.
Published: (2023-08-01) -
Targeted Axillary Biopsy with Preoperative Ultrasound-Guided Tattooing for Suspicious Axillary Lymph Nodes in Patients with Early Breast Cancer
by: Jin Hyang Jung, et al.
Published: (2020-11-01) -
Rare Bacterial Infection of the Stomach
by: Hyun Myung Cho, et al.
Published: (2024-06-01)